Antagonism of Betulinic Acid on LPS-Mediated Inhibition of ABCA1 and Cholesterol Efflux through Inhibiting Nuclear Factor-kappaB Signaling Pathway and miR-33 Expression

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Zhao, Guo Jun ^a   Tang, Shi Lin ^a   Lv, Yun Cheng ^a   Ouyang, Xin Ping ^a   He, Ping Ping ^a   Yao, Feng ^a   Chen, Wu Jun ^a   Lu, Qian ^a   Tang, Yan Yan ^a   Zhang, Min ^a   Fu, Yuchang ^b   Zhang, Da Wei ^c   Yin, Kai ^a   Tang, Chao Ke ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; BETULIC ACID; CHOLESTEROL; CHOLESTEROL ESTER; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MICRORNA; MICRORNA 33; MICRORNA 33A; MICRORNA 33B; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CELL NUCLEUS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MACROPHAGE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; ATP BINDING CASSETTE TRANSPORTER 1; BIOLOGICAL TRANSPORT; BODY WEIGHT; CELL LINE; CELL NUCLEUS; CHOLESTEROL; GENE EXPRESSION REGULATION; HUMANS; LIPIDS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICRORNAS; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRITERPENES;

EID: 84884542264     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074782     Document Type: Article

References (32)

1. Weber C, Noels H, (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17: 1410-1422.
2. Wang Z, Nakayama T, (2010) Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010: 535918.
3. Stoll G, Bendszus M, (2006) Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 37: 1923-1932.
4. Zhao GJ, Yin K, Fu YC, Tang CK, (2012) The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids. Mol Med 18: 149-158.
5. Lee J, Park Y, Koo SI, (2012) ATP-binding cassette transporter A1 and HDL metabolism: effects of fatty acids. J Nutr Biochem 23: 1-7.
6. Hao XR, Cao DL, Hu YW, Li XX, Liu XH, et al. (2009) IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner. Atherosclerosis 203: 417-428.
7. Yin K, Liao DF, Tang CK, (2010) ATP-binding membrane cassette transporter A1 (ABCA1): a possible link between inflammation and reverse cholesterol transport. Mol Med 16: 438-449.
8. Maitra U, Li L, (2013) Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin. Arterioscler Thromb Vasc Biol 33: 24-33.
9. Yogeeswari P, Sriram D, (2005) Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem 12: 657-666.
10. de Melo CL, Queiroz MG, Arruda FA, Rodrigues AM, de Sousa DF, et al. (2009) Betulinic acid, a natural pentacyclic triterpenoid, prevents abdominal fat accumulation in mice fed a high-fat diet. J Agric Food Chem 57: 8776-8781.
11. Takada Y, Aggarwal BB, (2003) Betulinic acid suppresses carcinogen-induced NF-kappa B activation through inhibition of I kappa B alpha kinase and p65 phosphorylation: abrogation of cyclooxygenase-2 and matrix metalloprotease-9. J Immunol 171: 3278-3286.
12. Tang SL, Chen WJ, Yin K, Zhao GJ, Mo ZC, et al. (2012) PAPP-A negatively regulates ABCA1, ABCG1 and SR-B1 expression by inhibiting LXRalpha through the IGF-I-mediated signaling pathway. Atherosclerosis 222: 344-354.
13. Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, et al. (2010) MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328: 1566-1569.
14. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, et al. (2010) MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328: 1570-1573.
15. Yu XH, Jiang HL, Chen WJ, Yin K, Zhao GJ, et al. (2012) Interleukin-18 and interleukin-12 together downregulate ATP-binding cassette transporter A1 expression through the interleukin- 18R/nuclear factor-kappaB signaling pathway in THP-1 macrophage-derived foam cells. Circ J 76: 1780-1791.
16. Tian GP, Chen WJ, He PP, Tang SL, Zhao GJ, et al. (2012) MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion. Biochimie 94: 2749-2755.
17. Yin K, Deng X, Mo ZC, Zhao GJ, Jiang J, et al. (2011) Tristetraprolin-dependent post- transcriptional regulation of inflammatory cytokine mRNA expression by apolipoprotein A-I: role of ATP-binding membrane cassette transporter A1 and signal transducer and activator of transcription 3. J Biol Chem 286: 13834-13845.
18. Yin K, Chen WJ, Zhou ZG, Zhao GJ, Lv YC, et al. (2012) Apolipoprotein A-I Inhibits CD40 Proinflammatory Signaling via ATP-Binding Cassette Transporter A1-Mediated Modulation of Lipid Raft in Macrophages. J Atheroscler Thromb 19: 823-836.
19. Mcgillicuddy FC, de la Llera MM, Hinkle CC, Joshi MR, Chiquoine EH, et al. (2009) Inflammation impairs reverse cholesterol transport in vivo. Circulation 119: 1135-1145.
20. Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, et al. (2011) Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 478: 404-407.
21. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, et al. (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45: 1169-1196.
22. Yuan Y, Li P, Ye J, (2012) Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosis. Protein Cell 3: 173-181.
23. Fitzgerald ML, Mujawar Z, Tamehiro N, (2010) ABC transporters, atherosclerosis and inflammation. Atherosclerosis 211: 361-370.
24. Lee D, Shin C, (2012) MicroRNA-target interactions: new insights from genome-wide approaches. Ann N Y Acad Sci 1271: 118-128.
25. Taganov KD, Boldin MP, Chang KJ, Baltimore D, (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103: 12481-12486.
26. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611.
27. Jennewein C, von Knethen A, Schmid T, Brüne B, (2010) MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. J Biol Chem 285: 11846-11853.
28. Gonzalez-Ramos R, Defrere S, Devoto L, (2012) Nuclear factor-kappaB: a main regulator of inflammation and cell survival in endometriosis pathophysiology. Fertil Steril 98: 520-528.
29. Chen H, Yang J, Zhang Q, Chen LH, Wang Q, (2012) Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-kappaB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression. Circ J 76: 995-1003.
30. Shih VF, Tsui R, Caldwell A, Hoffmann A, (2011) A single NFkappaB system for both canonical and non-canonical signaling. Cell Res 21: 86-102.
31. Rabi T, Shukla S, Gupta S, (2008) Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells. Mol Carcinog 47: 964-973.
32. Viji V, Shobha B, Kavitha SK, Ratheesh M, Kripa K, et al. (2010) Betulinic acid isolated from Bacopa monniera (L.) Wettst suppresses lipopolysaccharide stimulated interleukin-6 production through modulation of nuclear factor-kappaB in peripheral blood mononuclear cells. Int Immunopharmacol 10: 843-849.